Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -0.39% vs -5.59% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 21.97% vs 21.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 7.21% vs 21.82% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 2,100.00% vs -90.91% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Harbin Gloria Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -0.39% vs -5.59% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -12.57% vs -16.50% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 21.97% vs 21.85% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -0.40% vs 628.85% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 7.21% vs 21.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -10.11% vs 13.90% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2,100.00% vs -90.91% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -12.00% vs -77.48% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






